Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Headwaters Capital 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Headwaters Capital)

Primary Source Intelligence • Q3 2024 Letter Analysis

Headwaters Capital Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Headwaters Capital. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Digest Analysis

Quick Take

"Headwaters matched benchmarks in Q3 after strong outperformance streak. Manager sees continued small cap opportunity following Fed rate cuts, supported by cheap valuations and 2025 earnings growth outlook."

Executive Summary

Headwaters Capital returned 9.0% gross in Q3 2024, matching the Russell Mid Cap Index after three quarters of strong outperformance. The manager sees continued opportunity in small caps following the Fed's 50bps rate cut in September, noting historical patterns of small cap outperformance in easing cycles. Key contributors included Fair Isaac Corporation, benefiting from declining mortgage rates, and Climb Global, which posted strong growth in cybersecurity software distribution. Medpace declined due to biotech funding pressures but remains positioned for long-term growth with aggressive share buyback potential. The manager added Altus Group, a commercial real estate software company trading at depressed valuations ahead of a business divestiture catalyst. With cheap valuations both absolute and relative to large caps, plus an outlook for faster earnings growth in 2025, the manager believes all ingredients remain in place for ongoing small cap outperformance. The portfolio maintains focus on quality businesses with strong competitive positions and disciplined capital allocation.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

Manager demonstrates high conviction through detailed analysis of individual positions, particularly the extensive 15-page thesis on Altus Group with specific valuation targets and catalysts. Names specific positions with sizing context (FICO as largest contributor) and provides detailed fundamental analysis. However, diversified portfolio approach and measured language prevent maximum conviction scoring.

Growth Outlook

60%

BearishBullish

Neutral (60%)

Manager expresses constructive optimism about small cap opportunities following Fed rate cuts, citing historical patterns and attractive valuations. Discusses market inflection points in commercial real estate with narrowing bid-ask spreads. Language is positive but measured, acknowledging cyclical pressures while emphasizing fundamental support for continued outperformance.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

Portfolio positioning appears balanced with selective additions and sales. Manager added one new position (Altus Group) while selling another (National Vision), suggesting measured risk appetite. No indication of aggressive deployment or defensive positioning, maintaining steady exposure to small and mid-cap opportunities.

Capital Deployment

5%

De-riskingDeploying

De-risking (5%)

Limited net deployment activity with one addition (Altus Group) and one sale (National Vision), representing portfolio rotation rather than significant capital deployment. No mention of cash level changes or aggressive scaling of positions. Activity appears balanced between buys and sells.

Forward Guidance

50%

CautiousExpansionary

Neutral (50%)

Manager indicates continued focus on small cap positioning based on fundamental support but doesn't signal aggressive deployment plans. Forward guidance is steady and measured, maintaining current strategy rather than indicating significant directional changes in capital deployment.

Language Signal

45%

BearishBullish

Balanced (45%)

Language balance tilts slightly positive with terms like 'opportunity,' 'outperformance,' 'attractive valuations,' and 'inflection point.' However, manager also discusses cyclical pressures, frozen markets, and operational challenges, creating a balanced but cautiously optimistic tone overall.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Manager acknowledges specific risks including frozen commercial real estate markets, biotech funding pressures, and cyclical challenges. However, these are presented as manageable within secular growth themes rather than systemic threats. Risk discussion is balanced and contextual rather than alarming.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Manager sees selective opportunities in small caps supported by rate cuts and valuations, plus specific opportunities like Altus Group trading at depressed valuations. Discussion suggests good opportunity set in targeted areas rather than broad market abundance, requiring selectivity and patience.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Manager demonstrates multi-year investment horizon, particularly evident in Medpace discussion about weathering cyclical volatility for long-term per-share earnings growth. Altus Group thesis spans 2026 targets. Emphasis on long-term business quality over short-term trading, though some catalyst dependency noted.